Shockwave Therapy for Erectile Dysfunction in London: What the Evidence Shows

Erectile dysfunction is one of the most common conditions I see at my clinic in Notting Hill Gate — and one of the most undertreated. Not because effective treatment does not exist, but because most men either do not seek help, or they are offered only one option: medication.

The conversation around shockwave therapy for erectile dysfunction has changed significantly over the past decade. What began as a promising experimental treatment is now a guideline-endorsed clinical option, backed by multiple randomised controlled trials and recognised by the European Association of Urology. The evidence is no longer preliminary — it is substantial.

This guide covers what shockwave therapy for ED actually involves, how it works biologically, what the clinical trials show, who it is most likely to help, and what to expect from treatment in London. I have tried to write this the way I would explain it to a patient sitting in front of me — plainly, accurately, and without overstating what the treatment can and cannot do.

Understanding Erectile Dysfunction: The Vascular Root Cause

Before discussing the treatment, it is worth being precise about the condition.

Erectile dysfunction is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects an estimated 4.3 million men in the UK, with prevalence increasing significantly with age — affecting approximately 40% of men at 40 and rising to 70% by age 70.

The majority of cases — particularly in men over 40 — have a vascular cause. A normal erection requires the smooth muscle of the penile arteries to relax, allowing blood to flow into the corpus cavernosum under sufficient pressure. This process is initiated by the release of nitric oxide and depends entirely on the health of the endothelium — the inner lining of the blood vessels.

In men with vasculogenic ED, the endothelium is damaged or dysfunctional. The penile arteries become narrowed, less responsive to nitric oxide, and unable to deliver adequate blood flow. This is the same mechanism responsible for cardiovascular disease — which is why ED is now considered an early warning sign of cardiovascular risk. A landmark study published in Circulation found that men with ED had a 44% increased risk of cardiovascular events, and that ED typically precedes cardiac symptoms by three to five years.

This vascular understanding is fundamental to why shockwave therapy works — and why medication, which does not address the vascular cause, produces results that diminish over time.

How Shockwave Therapy Treats Erectile Dysfunction

Low-intensity focal shockwave therapy (Li-ESWT) is not a symptomatic treatment for ED. It is a biological treatment that targets the vascular cause of the condition directly.

When focused acoustic energy waves are delivered to the erectile tissue and penile arteries, they create a mechanical stimulus at the cellular level. This triggers a cascade of biological repair processes:

1. Angiogenesis — New Blood Vessel Formation

The acoustic waves stimulate the release of vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and other angiogenic mediators. These promote the growth of new capillaries within the erectile tissue — increasing the total vascular supply to the penis and improving the blood flow that erectile function depends on.

2. Endothelial Repair

Shockwave therapy promotes the upregulation of endothelial nitric oxide synthase (eNOS) — the enzyme responsible for producing nitric oxide, which triggers smooth muscle relaxation and blood inflow. In men with endothelial dysfunction, nitric oxide production is impaired. Focal shockwave therapy helps restore this at the cellular level.

3. Neuroregeneration

Emerging evidence suggests that shockwave therapy promotes regeneration of nerve fibres within the penile tissue — relevant particularly in men with neurogenic ED, such as those who have undergone prostate surgery.

4. Stem Cell Activation

Shockwave therapy has been shown to activate resident stem cells in the erectile tissue, promoting tissue remodelling and cellular repair that contributes to long-term functional improvement.

The combined effect of these mechanisms is genuine biological repair of the vascular tissue responsible for erectile function. This is why the results of focal shockwave therapy persist after the treatment course is complete — the improvement reflects real change in the tissue, not a pharmacological effect that wears off.

The Clinical Evidence

The evidence base for focal shockwave therapy in ED has grown substantially since the first clinical trials were published in the early 2010s. Here is an honest summary of what the research shows.

Key Clinical Trials

Guideline Recognition

The European Association of Urology (EAU) — the leading European professional body in urology — formally recognises low-intensity shockwave therapy as a therapeutic option for vasculogenic ED in its 2024 Guidelines on Sexual and Reproductive Health.

Focal vs Radial Shockwave for ED: Why the Distinction Is Critical

This is a point I feel strongly about — and one that is frequently misrepresented in clinic marketing materials.

The evidence base for shockwave therapy in erectile dysfunction is built entirely on focal shockwave devices. Radial shockwave devices — which generate pressure waves that spread outward from the surface — do not achieve the tissue depth required to deliver therapeutic energy to the corpus cavernosum and penile arteries, which sit 5-8cm below the skin surface.

Delivering radial shockwave therapy for ED is not evidence-based. It is using a device that cannot physically reach the target tissue and applying the evidence from focal device trials to justify its use. These are not equivalent, and the distinction matters clinically.

At Shockwave ReVibe Clinic, we use exclusively focal shockwave technology — the EMS Dolorclast Focal Shockwave system. When you come to us for ED treatment, you receive the device and protocol validated in the published clinical trials. This is not a detail. It is the clinical standard.

Who Is Shockwave Therapy Most Likely to Help?

Based on the published evidence and my own clinical experience, focal shockwave therapy for ED is most effective in:

• Men with mild to moderate vasculogenic ED. The vascular cause of ED is the most amenable to biological repair. Men with mild to moderate ED who have a clearly vascular aetiology — particularly those with cardiovascular risk factors such as diabetes, hypertension, or a history of smoking — are the best candidates.
• Men who want to reduce or eliminate reliance on PDE5 inhibitors. For men who are taking Viagra or Cialis and want to restore natural spontaneous function without ongoing medication, shockwave therapy offers a clinically realistic pathway.
• Men who have stopped responding to PDE5 inhibitors. As ED progresses and vascular damage accumulates, PDE5 inhibitors become progressively less effective. Shockwave therapy can restore sufficient vascular function for medication to work again in men who have stopped responding.
• Men who cannot take PDE5 inhibitors. Nitrate medications — prescribed for certain heart conditions — are an absolute contraindication to Viagra and all PDE5 inhibitors. Shockwave therapy has no drug interactions and is safe in these patients.
• Men following prostate surgery. Penile rehabilitation following radical prostatectomy is a recognised clinical indication for shockwave therapy. The neuroregeneration effects are relevant to men whose ED has a neurogenic component following surgical nerve disruption.

Who Is Less Likely to Benefit?

I want to be honest about this. Focal shockwave therapy is not effective for every man with ED:

• Men with severe ED and significant vascular damage may see less dramatic results
• Men with predominantly psychological ED — in whom the cause is anxiety rather than vascular dysfunction — are better served by psychosexual assessment and management
• Men with non-vascular causes of ED (hormonal, neurological, medication-induced) may not see meaningful improvement

A proper clinical assessment is essential to establish which category you fall into before committing to treatment. This is the first thing I do with every patient.

What to Expect from Treatment at Shockwave ReVibe Clinic

The consultation

Every patient begins with a comprehensive clinical assessment. This covers your medical history, current medications, symptom history, relevant investigations, and psychosexual context where relevant. I use validated assessment tools — including the IIEF-EF questionnaire — to establish a baseline before treatment begins, allowing objective tracking of improvement.

The treatment course

For ED, our standard protocol consists of 6 treatment sessions, each lasting approximately 20-25 minutes. A handheld focal shockwave applicator is placed against the shaft and base of the penis and perineum, delivering precisely focused acoustic pulses to the erectile tissue and penile arterial supply.

Most patients describe the sensation as mild pressure or light tapping. Treatment is not painful. No anaesthesia is required. There is no downtime — you return to normal activity immediately after each session. Sessions are typically scheduled weekly or bi-weekly.

The results timeline

The biological processes initiated by focal shockwave therapy — angiogenesis, endothelial repair, tissue remodelling — take time to complete. Most patients begin to notice improvement during or shortly after the treatment course. The full benefit typically consolidates over 6-12 weeks following the final session.

This is different from medication, which produces an effect within an hour and wears off. The results of shockwave therapy are slower to appear but, when they come, they reflect genuine biological improvement rather than a pharmacological override. Lifestyle factors also play a meaningful role in how well treatment performs — see our guide on diet, exercise and sleep for erectile function.

Follow-up

I reassess every patient at 12 weeks following the treatment course using the IIEF-EF questionnaire and clinical review. Treatment response is documented objectively. For men who would benefit from a second course, this is discussed at follow-up.

Shockwave Therapy vs Medication: A Direct Comparison

For a fuller discussion of how these two approaches differ, see our dedicated comparison: Shockwave Therapy vs Viagra. The key differences are summarised below.

Frequently Asked Questions